111 related articles for article (PubMed ID: 11125556)
1. Inhibition of transforming growth factor-beta 1 gene overexpression as a strategy to prevent fibrosis.
Gambaro G; Weigert C; Ceol M; Schleicher ED
Contrib Nephrol; 2001; (131):107-13. PubMed ID: 11125556
[No Abstract] [Full Text] [Related]
2. Strategy for preventing peritoneal dialysis failure.
Cancarini G
Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
[No Abstract] [Full Text] [Related]
3. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Yang LY; Chen A; Huang TP
Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
[TBL] [Abstract][Full Text] [Related]
4. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
Zhou Q; Bajo MA; Del Peso G; Yu X; Selgas R
Kidney Int; 2016 Sep; 90(3):515-24. PubMed ID: 27282936
[TBL] [Abstract][Full Text] [Related]
5. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of peritoneal dialysis on peritoneal morphology.
Dobbie JW; Anderson JD; Hind C
Perit Dial Int; 1994; 14 Suppl 3():S16-20. PubMed ID: 7948267
[No Abstract] [Full Text] [Related]
7. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
[TBL] [Abstract][Full Text] [Related]
8. A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects.
Cappelli G; Amore A; Bandiani G; Cancarini G; Coppo R; Feriani M; Dell'Aquila R; Saffioti S; Spisni C; Stingone A; Orazi E; Ballocchi S; Renaux JL
Contrib Nephrol; 2001; (131):97-106. PubMed ID: 11125568
[No Abstract] [Full Text] [Related]
9. Inhibiting effect of short hairpin RNA on expression of transforming growth factor-beta1 in human peritoneal mesothelial cells induced by peritoneal dialysis solution.
Liu FY; Ling GH; Liu H; Peng YM; Liu YH; Duan SB
Chin Med J (Engl); 2005 Sep; 118(18):1552-6. PubMed ID: 16232333
[No Abstract] [Full Text] [Related]
10. Peritoneal dialysis in diabetic patients.
Bertoli M; Bonfante L; Gambaro G; Cara M; Virgilio B; D'Angelo A
Contrib Nephrol; 2001; (131):51-60. PubMed ID: 11125563
[No Abstract] [Full Text] [Related]
11. Long-term peritoneal dialysis-impact of peritoneal membrane changes and newer solutions.
Krediet RT
Int J Artif Organs; 1998 Aug; 21(8):437-9. PubMed ID: 9803343
[No Abstract] [Full Text] [Related]
12. The dialytic failure of the peritoneal membrane.
Lupo A; Rugiu C; Lapolla A; Maiorca P; Aricó CN; Bernich P; Marcantoni C; Brezzi B; Maschio G
Contrib Nephrol; 2001; (131):90-6. PubMed ID: 11125567
[No Abstract] [Full Text] [Related]
13. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal dialysis in diabetic patients.
Lee HB; Chung SH; Chu WS; Kim JK; Ha H
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S200-3. PubMed ID: 11576955
[TBL] [Abstract][Full Text] [Related]
15. Clinical research in peritoneal dialysis.
Coles GA
Contrib Nephrol; 2001; (131):125-31. PubMed ID: 11125558
[No Abstract] [Full Text] [Related]
16. Protein kinase C in diabetic nephropathy.
Craven PA; Studer RK; Negrete H; DeRubertis FR
J Diabetes Complications; 1995; 9(4):241-5. PubMed ID: 8573737
[TBL] [Abstract][Full Text] [Related]
17. Membrane viability in the long-term peritoneal dialysis patient.
Schreiber MJ
Perit Dial Int; 1997; 17 Suppl 3():S19-24. PubMed ID: 9304652
[No Abstract] [Full Text] [Related]
18. Advanced glycosylation end products in peritoneal tissue with different solutions.
Dobbie JW
Perit Dial Int; 1997; 17 Suppl 2():S27-30. PubMed ID: 9163793
[No Abstract] [Full Text] [Related]
19. Peritoneal transport in long-term peritoneal dialysis patients and its relation with AGEs.
Feriani M
Contrib Nephrol; 2001; (131):74-81. PubMed ID: 11125565
[No Abstract] [Full Text] [Related]
20. Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-kappaB in peritoneal mesothelial cells.
Matsuo H; Tamura M; Kabashima N; Serino R; Tokunaga M; Shibata T; Matsumoto M; Aijima M; Oikawa S; Anai H; Nakashima Y
Kidney Int; 2006 Feb; 69(4):736-46. PubMed ID: 16518329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
